132 related articles for article (PubMed ID: 21315223)
1. Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention.
Ko YG; Suh JW; Kim BH; Lee CJ; Kim JS; Choi D; Hong MK; Seo MK; Youn TJ; Chae IH; Choi DJ; Jang Y
Am Heart J; 2011 Feb; 161(2):383-90. PubMed ID: 21315223
[TBL] [Abstract][Full Text] [Related]
2. Different influences of hematocrit on the results of two Point-Of-Care platelet function tests, the VerifyNow assay and multiple electrode platelet aggregometry.
Kim YG; Suh JW; Park JJ; Oh IY; Yoon CH; Cho YS; Youn TJ; Chae IH; Choi DJ
PLoS One; 2014; 9(11):e114053. PubMed ID: 25427105
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
[TBL] [Abstract][Full Text] [Related]
4. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.
Paniccia R; Antonucci E; Gori AM; Marcucci R; Poli S; Romano E; Valente S; Giglioli C; Fedi S; Gensini GF; Abbate R; Prisco D
Am J Clin Pathol; 2007 Jul; 128(1):143-9. PubMed ID: 17580282
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G
J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
[TBL] [Abstract][Full Text] [Related]
9. Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry.
von Beckerath N; Sibbing D; Jawansky S; Braun S; Morath T; Vogt W; Schömig A; Kastrati A
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):46-52. PubMed ID: 19823079
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
Sibbing D; Morath T; Braun S; Stegherr J; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2010 Jan; 103(1):151-9. PubMed ID: 20062919
[TBL] [Abstract][Full Text] [Related]
12. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
[TBL] [Abstract][Full Text] [Related]
13. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
Sibbing D; Braun S; Jawansky S; Vogt W; Mehilli J; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2008 Jan; 99(1):121-6. PubMed ID: 18217143
[TBL] [Abstract][Full Text] [Related]
14. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.
Paniccia R; Antonucci E; Maggini N; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
Am J Clin Pathol; 2009 Jun; 131(6):834-42. PubMed ID: 19461090
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
[TBL] [Abstract][Full Text] [Related]
16. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.
Price MJ; Nayak KR; Barker CM; Kandzari DE; Teirstein PS
Am J Cardiol; 2009 May; 103(10):1339-43. PubMed ID: 19427425
[TBL] [Abstract][Full Text] [Related]
17. Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.
Paniccia R; Antonucci E; Maggini N; Miranda M; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
Ther Drug Monit; 2011 Feb; 33(1):94-8. PubMed ID: 21192314
[TBL] [Abstract][Full Text] [Related]
18. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
[TBL] [Abstract][Full Text] [Related]
19. Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel.
Hochholzer W; Trenk D; Frundi D; Neumann FJ
Thromb Res; 2007; 119(3):285-91. PubMed ID: 16603231
[TBL] [Abstract][Full Text] [Related]
20. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.
van Werkum JW; Harmsze AM; Elsenberg EH; Bouman HJ; ten Berg JM; Hackeng CM
Platelets; 2008 Nov; 19(7):479-88. PubMed ID: 18979359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]